Earlier detection of tumor treatment response using magnetic resonance diffusion imaging with oscillating gradients

Choyke, 2003, Functional tumor imaging with dynamic contrast enhanced magnetic resonance imaging, J Magn Reson Imaging, 17, 509, 10.1002/jmri.10304 Jordan, 2005, Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478, Neoplasia, 7, 475, 10.1593/neo.04628 Padhani, 2005, Antivascular cancer treatments: functional assessments by dynamic contrast-enhanced magnetic resonance imaging, Abdom Imaging, 30, 324, 10.1007/s00261-004-0265-5 Yankeelov, 2007, Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer initial results, Magn Reson Imag, 25, 1, 10.1016/j.mri.2006.09.006 Sugahara, 1999, Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas, J Magn Reson Imaging, 9, 53, 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2 Lyng, 2000, Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging, Magn Reson Med, 43, 828, 10.1002/1522-2594(200006)43:6<828::AID-MRM8>3.0.CO;2-P Sinha, 2002, In vivo diffusion-weighted MRI of the breast: potential for lesion characterization, J Magn Reson Imaging, 15, 693, 10.1002/jmri.10116 Humphries, 2007, Tumors in pediatric patients at diffusion-weighted MR imaging: apparent diffusion coefficient and tumor cellularity, Radiology, 245, 848, 10.1148/radiol.2452061535 Zhao, 1996, Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo, Br J Cancer, 73, 61, 10.1038/bjc.1996.11 Seierstad, 2007, Early changes in apparent diffusion coefficient predict the quantitative antitumoral activity of capecitabine, oxaliplatin, and irradiation in HT29 xenografts in athymic nude mice, Neoplasia, 9, 392, 10.1593/neo.07154 McConville, 2007, Magnetic resonance imaging determination of tumor grade and early response to temozolomide in a genetically engineered mouse model of glioma, Clin Cancer Res, 13, 2897, 10.1158/1078-0432.CCR-06-3058 Morse, 2007, MRI-measured water mobility increases in response to chemotherapy via multiple cell-death mechanisms, NMR Biomed, 20, 602, 10.1002/nbm.1127 Theilmann, 2004, Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy, Neoplasia, 6, 831, 10.1593/neo.03343 Schepkin, 2006, Sodium and proton diffusion MRI as biomarkers for early therapeutic response in subcutaneous tumors, Magn Reson Imaging, 24, 273, 10.1016/j.mri.2005.12.004 Colvin, 2008, New insights into tumor microstructure using temporal diffusion spectroscopy, Cancer Res, 68, 5941, 10.1158/0008-5472.CAN-08-0832 Laws, 2003, Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the gliomas outcome project, J Neurosurg, 99, 467, 10.3171/jns.2003.99.3.0467 Stupp, 2005, Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma, N Engl J Med, 352, 987, 10.1056/NEJMoa043330 Barker, 1973, Development of an animal brain tumor model and its response to therapy with 1,3-Bis(2-chloroethyl)-1-nitrosourea, Cancer Res, 33, 976 Walker, 1978, Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial, J Neurosurg, 49, 333, 10.3171/jns.1978.49.3.0333 Buckner, 1995, Phase II evaluation of recombinant interferon alpha and BCNU in recurrent glioma, J Neurosurg, 82, 430, 10.3171/jns.1995.82.3.0430 Westphal, 2003, A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma, Neuro-oncol, 5, 79, 10.1093/neuonc/5.2.79 Fine, 2003, Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas, J Clin Oncol, 21, 2299, 10.1200/JCO.2003.08.045 Feun, 1995, Phase II trial of recombinant interferon-alpha with BCNU, cisplatin, DTIC and tamoxifen in advanced malignant melanoma, Melanoma Res, 5, 273, 10.1097/00008390-199508000-00011 Phillips, 1983, Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II study, Cancer, 52, 1792, 10.1002/1097-0142(19831115)52:10<1792::AID-CNCR2820521006>3.0.CO;2-D Tchekmedyian, 1986, High-dose chemotherapy without autologous bone marrow transplantation in melanoma, J Clin Oncol, 4, 1811, 10.1200/JCO.1986.4.12.1811 Elias, 1993, Intensive combined modality therapy for limited-stage small-cell lung cancer, JNCI J Natl Cancer Inst, 85, 559, 10.1093/jnci/85.7.559 Turrisi, 2002, The treatment of limited small cell lung cancer: a report of the progress made and future prospects, Eur J Cancer, 38, 279, 10.1016/S0959-8049(01)00364-1 Rosenblum, 1975, In vitro evaluation of in vivo brain tumor chemotherapy with 1,3-bis(2-chloroethyl)-nitrosourea, Cancer Res, 35, 1387 Rosenblum, 1976, In vivo clonogenic tumor cell kinetics following 1,3-bis(2-chloroethyl)-1-nitrosourea brain tumor therapy, Cancer Res, 36, 2718 Kim, 1995, Growth kinetics and treatment response of the intracerebral rat 9L brain tumor model: a quantitative in vivo study using magnetic resonance imaging, Clin Cancer Res, 1, 643 Ross, 1998, Contributions of cell kill and posttreatment tumor growth rates to the repopulation of intracerebral 9L tumors after chemotherapy: an MRI study, Proc Natl Acad Sci USA, 95, 7012, 10.1073/pnas.95.12.7012 Neeman, 1991, A simple method for obtaining cross-term-free images for diffusion anisotropy studies in NMR microimaging, Magn Reson Med, 21, 138, 10.1002/mrm.1910210117 Rasband WS. ImageJ: Image Processing and Analysis in Java. Available at: http://rsb.info.nih.gov/ij. Taxt, 1992, Multispectral analysis of uterine corpus tumors in magnetic resonance imaging, Magn Reson Med, 23, 55, 10.1002/mrm.1910230108 Pham, 2000, Current methods in medical image segmentation, Annu Rev Biomed Eng, 2, 315, 10.1146/annurev.bioeng.2.1.315 Gurcan, 2002, Lung nodule detection on thoracic computed tomography images: preliminary evaluation of a computer-aided diagnosis system, Med Phys, 29, 2552, 10.1118/1.1515762 Stejskal, 1965, Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient, J Chem Phys, 42, 288, 10.1063/1.1695690 Parsons, 2003, Modified oscillating gradient pulses for direct sampling of the diffusion spectrum suitable for imaging sequences, Magn Reson Imag, 21, 279, 10.1016/S0730-725X(03)00155-3 Arima, 1997, Stereologically estimated mean nuclear volume of prostate cancer is a reliable prognostic parameter, Br J Cancer, 76, 234, 10.1038/bjc.1997.367 Hsu, 2005, Nuclear size distinguishes low- from high-grade ovarian serous carcinoma and predicts outcome, Hum Pathol, 36, 1049, 10.1016/j.humpath.2005.07.014 Zink, 2004, Nuclear structure in cancer cells, Nat Rev Cancer, 4, 677, 10.1038/nrc1430 Xu, 2009, Sensitivity of MR diffusion measurements to variations in intracellular structure: effects of nuclear size, Magn Reson Med, 61, 828, 10.1002/mrm.21793 Does, 2003, Oscillating gradient measurements of water diffusion in normal and globally ischemic rat brain, Magn Reson Med, 49, 206, 10.1002/mrm.10385